申请人:SHIONOGI SEIYAKU KABUSHIKI KAISHA
公开号:EP0464845A1
公开(公告)日:1992-01-08
The compounds of the present invention inhibit the HMG-CoA reductase, and subsequently suppress the synthesis of cholesterol. And they are useful in the treatment of hypercholesterolemia, hyperlipoproteinemia, and atherosclerosis.
本发明的化合物可抑制
HMG-CoA 还原酶,从而抑制
胆固醇的合成。 它们可用于治疗高
胆固醇血症、高脂蛋白血症和动脉粥样硬化。